Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Roche withdraws Tecentriq combo application in first-line renal cell carcinoma

November 19, 2018 Sales and Marketing Cancer, Roche, avastin, pharma, renal cell carcinoma, tecentriq

The EMA has revealed that Roche has chosen to withdraw its marketing application for immunotherapy Tecentriq (atezolizumab) in combination with …
News

EU rules may be stifling Britain’s biotech industry

November 19, 2018 Sales and Marketing EU, biotech, britain, funding, grants, industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …
News

MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund

November 19, 2018 Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …
News

FDA trial may help to cut the number of dogs used in clinical trials

November 19, 2018 Sales and Marketing Animal testing, animal activists, clinical trials, dogs, health, tests

A new study may help to significantly reduce the number of dogs that are used in clinical trials, according to …
News

Alector strengthens board with three appointments including Facebook CFO David Wehner

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
Appointment

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
News

Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma

November 16, 2018 Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission

Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …
News

Dermavant appoint Todd Zavodnick as CEO

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …
Appointment

Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
Feature

Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund

November 15, 2018 Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma

NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …
News

Company tackling antimicrobial resistance appoint former Bayer VP as new managing director

November 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …
Appointment

Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs

November 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
Appointment

AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn

November 13, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi

AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …
News

MSD’s Keytruda chalks up FDA approval in liver cancer

November 12, 2018 Sales and Marketing Cancer, FDA, US, hepatocellular carcinoma, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda has secured another FDA approval, this time for the treatment of hepatocellular carcinoma (HCC) in patients …
News

Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma

November 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
Feature
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026